BIOMAT Database Logo BIOMAT Database Logo

Relationship between Kaposi sarcoma-associated herpesvirus and HIV. 2002

Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert

UI MeSH Term Description Entries
D008297 Male Males
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012495 San Francisco A city in northern California.
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Relationship between Kaposi sarcoma-associated herpesvirus and HIV.
March 2002, JAMA,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Relationship between Kaposi sarcoma-associated herpesvirus and HIV.
March 2002, JAMA,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and Kaposi sarcoma.
April 2011, Advances in dental research,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Kaposi Sarcoma-Associated Herpesvirus (KSHV).
March 2020, Trends in microbiology,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
[Kaposi sarcoma-associated herpesvirus; human herpesvirus 8].
April 1997, Orvosi hetilap,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity.
August 2004, Blood,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus.
September 2002, Current opinion in oncology,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.
June 1996, Proceedings of the National Academy of Sciences of the United States of America,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
[Human herpesvirus 8. A Kaposi sarcoma-associated herpesvirus?].
August 1997, Ugeskrift for laeger,
Thomas R O'Brien, and Eric A Engels, and Phillip S Rosenberg, and James J Goedert
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma.
April 1998, Current opinion in infectious diseases,
Copied contents to your clipboard!